DOCSLIB.ORG

Characteristics and Use of Urania-Gadolinia Fuels

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Characteristics and Use of Urania-Gadolinia Fuels IAEA-TECDOC-844 Characteristics and use of urania-gadolinia fuels INTERNATIONAL ATOMIC ENERGY AGENCY The IAEA does not normally maintain stocks of reports in this series. However, microfiche copies of these reports can be obtained from INIS Clearinghouse International Atomic Energy Agency Wagramerstrasse 5 0 10 P.Ox Bo . A-1400 Vienna, Austria Orders should be accompanied by prepayment of Austrian Schillings 100, in the form of a cheque or in the form of IAEA microfiche service coupons which may be ordered separately from the INIS Clearinghouse. originatine Th g Sectio f thino s publicatio IAEe th An i was: Nuclear Material Fued san l Cycle Technology Section International Atomic Energy Agency Wagramerstrasse5 0 10 x P.OBo . A-1400 Vienna, Austria CHARACTERISTICS AND USE OF URANIA-GADOLINIA FUELS IAEA, VIENNA, 1995 IAEA-TECDOC-844 ISSN 1011-4289 © IAEA, 1995 Printe IAEe th AustriAn y i d b a November 1995 PLEASE BE AWARE THAT MISSINE TH AL F LO G PAGE THIN SI S DOCUMENT WERE ORIGINALLY BLANK FOREWORD In BWRs, the issue of power mismatch between fresh fuel assemblies and partially burned fuel assemblies causing the power in the former to be depressed was recognized at an early stage. Since the earlier absorbers used to address this issue presented inconveniences, the use of gadolinium in urania-gadolinia fuel became routine in all BWRs soon afte decisioe th r f Generano l Electri implemeno ct Dresden mid-1960se i t th i t n i n2 . fueR l vendorBW e th l sAl have since progressively adopte dtotae gadoliniath f f o l o t Ou . 420 reactors around the world with an installed capacity of 330 GW(e), approximately 90, wit installen ha d capacit GW(e)0 7 f BWRsyo e ar , . Experience with gadolinia ove pase rth t twenty years has become statistically significant, providing confidence in the concept. When advanced duty conditions (i.e. extended burnup, increased reactor cycle lengths and/or in-out core refuelling schemes) were considered and implemented in PWRs, f burnablo e us e th absorber r thasfo t reactor type also came into consideration. Theres i an obvious advantag t sacrificinno n ei fuee positiond gth ro l r burnablsfo e absorberso s , integral burnable absorbe attractivn a r fues wa l e choice gooe .Th d experience accumulated with gadolini face ath tfued thaan l t some fuel vendors were fabricatind an g R bothBW PWR fuel made gadolini prime ath e choic meeo et needse th t . recene Inth t past extendee ,th d dutie fuelR ,sPW considerer fo d an R d botBW r hfo an perceivee dth d advantage usinn si g burnable absorber WWERn s i same th r esfo reasons aPWRn i s s increase e prospectdth r gadolinisfo a utilizatio hastened nan e needth r dfo higher gadolinia contents. Against this background IAEe ,th A considere t dappropriati o et launch in 1990 a Co-ordinated Research Programme on Technology and Performance of Integrated Burnable Absorbers for Water Reactor Fuel (in short "BAF"). The aim was to issue a report summarizing the various aspects of burnable absorber utilization. The participation was on a voluntary basis. This report is the result of the inputs of the participant Co-ordinatee th o st d Research Programme. The IAEA would like to express its appreciation for the work performed by the participants and, in particular, to acknowledge the contributions of H. Bairiot (Belgium), D. Farrant (United Kingdom . OnufrieV d an ) v (Russian Federation e draftinth n d i ) gan review of this report. The scientific secretaries of the programme were successively P. Chantoin and G. Sukhanov of the IAEA, Division of Nuclear Fuel Cycle and Waste Management. EDITORIAL NOTE In preparing this publication for press, staff of the IAEA have made up the pages from the original manuscript (s). The views expressed do not necessarily reflect those of the governments of the nominating Member States or of the nominating organizations. Throughout the text names of Member States are retained as they were when the text was compiled. The use of particular designations of countries or territories does not imply any judgement by publisher,the legalthe IAEA, to status the as of such countries territories,or of their authoritiesand institutions delimitationthe of or theirof boundaries. The mention of names of specific companies or products (whether or not indicated as registered) does implyintentionnot any infringeto proprietary rights, should construednor be it an as endorsement or recommendation on the part of the IAEA. CONTENTS INTRODUCTION ...............................................7 . 1. STRATEGIC CONSIDERATIONS FOR THE USE OF BURNABLE ABSORBERS .... 9 1.1. Introduction ............................................. 9 1.2. Applications of burnable absorbers ............................. 9 1.3. Advantages and disadvantages of burnable absorber fuel ............. 10 1.4. Choice f integrateso d burnable absorbers .......................2 1 . UNIRRADIATE2 D GADOLINIA FUEL PROPERTIES ......................7 1 . 2.1. Structure and chemistry of the (U,Gd)O2 solid solutions .............. 17 2.2. Physical properties .......................................3 2 . 2.3. Mechanical properties .....................................0 4 . 2.4. Neutronic properties ....................................... 44 3. FUEL MANUFACTURING ......................................0 5 . 3.1. Fabrication processes ...................................... 50 3.2. Quality control ........................................... 53 4. DESIGN AND MODELLING CONSIDERATIONS ........................ 59 4.1. Principle f gadoliniso a fuel rod, assembl reactod yan r core design ......9 5 . 4.2. Modelling .............................................5 7 . EXPERIENC5 E WITH GADOLINIA FUEL .............................3 8 . 5.1. Utilizatio f gadolinino a fuel ................................3 8 . 5.2. Nuclear dat Neutronia— c measurements .......................0 9 . 5.3. Thermal-mechanical behaviour ..............................2 9 . 5.4. Behaviour under reactivity initiated accidents ..................... 99 . FUE6 L CYCLE BAC......................................D KEN 3 10 . 7. CONCLUSIONS ............................................. 105 APPENDI : XI GADOLINIU ERBIUD REVIEA MAN M- RESOURCE F WO S AND SUPPLY ...................................... 107 APPENDIX II: GADOLINA FUEL UTILIZATION IN FRANCE ................. 114 APPENDIX III: GADOLINIA FUEL UTILIZATION IN JAPAN ................. 121 APPENDI : GADOLINIXIV A FUEL UTILIZATIO REPUBLIE 1 TH NN 15 KOREI F CO . .. A APPENDI : XGADOLINIV A FUEL UTILIZATIO BELGIUNN I M ..............7 17 . ABBREVIATIONS .............................................5 18 . PARTICIPANTS IN THE CO-ORDINATED RESEARCH PROGRAMME ........... 191 INTRODUCTION Burnable absorber fuels (BAF utilizede beine ar ) ar r g,o considere r utilizationdfo n ,i l BWRsal mosn i , t PWR mord san e recentl WWERsn yi topie thereforTh s c.i e relevano t approximately 330 out of the 420 operating reactors in the world, representing 280 of the GW(e0 33 ) installed capacity worldwide lighe f th thi o t n sI . importance IAEe s th , Aha decide issudo t e this report providin overaln ga lvariou e vieth f wo s aspect f BAFso . With e exceptioth f Chapte no e whol th , e1 r repor devotes i t urania-gadolinio dt a fuel ("Gd fuel")1, the most commonly used BAF, and a comprehensive technical review of this topic provideds i , althoug repore hth t doe t includsno completea e surve l examplesal f yo d G f o utilization throughou industrye th t repore Th organize.s i t followine th dn i g way: Chapter 1. Strategic considerations: describes the reasons for application of BAFs, their advantage disadvantaged san varioue th d ssan absorbers being utilized. underlyine Th larga o t eg e extensucces fuedu d s G almoso i lt t f so 0 3 t years industrial utilizatio BWRsnn i applicatioe Th . PWRno t mors i e recent, as more challengin coresgR condition addition I PW . n i t no t me s e havb o et Gd fuel alternativo ,tw typeF eBA s have been develope utilizee ar d dn i dan commercial PWRs. They present advantages and disadvantages which are compare thin di s chapter. Chapter 2. Unirradiated gadolinia fuel properties: outlines the differences between Gd fuel propertie fueU d l propertiessan . homogeneousls i Eved G nf i y disperse uraniue th dn i m oxide matrix t woul,i d normally be expected to affect the properties of the fuel for three reasons. Firstly naturae th , l structur oxid d body-centerea G s ef i e o d cubic lattice, while U oxide is a face-centered cubic lattice. Secondly, Gd is a trivalent atom, unlik whic, eU tetravalenhs i nuclean i t r fuel. Thirdly absorptioe ,th n cross sections of the various Gd isotopes interfere with the resonances of the U isotopes. Both of the first two differences influence or are likely to influence the physical and mechanical properties of BAF in "as-fabricated" conditions. Moreover, the fabrication technique influences the dispersion of Gd within the fuel. Chapter 3. Fuel manufacturing: deals with the specific fabrication processes and quality control techniques for Gd fuel. Although fabrication techniques to produce perfectly homogenous Gd fuels have been developed l industriaal , l fabrication processe basee a sar n do mechanical blending of the two ingredients. Specific quality controls are implemented to verify the proper dispersion of Gd within the BAF fuel and specifiee th d fuepositioninF lfue e BA rod th e l n sth assemblyi f go . Chapte . 4 r Desig modellind nan g considerations: describe specifie th w csho properties of Gd fuel and the manufacturing constraints are taken into account for utilization of Gd in BWRs, PWRs and WWERs and how the modelling codes incorporate Gd fuel properties. 1 urania-gadolinia fuel is usually called "gadolinia fuel" within the nuclear industry. In this report, for convenience, the abbreviation "Gd fuel" is being used. Design flexibility is afforded by the use of Gd: the location of the Gd fuel rods within the fuel assembly and the axial shaping of the Gd along the Gd fue tunele rodsb varioun do t ,ca s design objectives (e.g. reduced fabrication cost, improved design margins, improved reactivity evolution and so on).
Load more

Recommended publications
  • Gadolinium Information
    Gadolinium Information Gadolinium contrast agents are frequently utilized during MRI examinations in order to improve the exam and interpretation. They are not always needed. Your radiologist will determine whether or not gadolinium contrast is needed for your MRI examination. Gadolinium contrast agents are quickly eliminated from the body in healthy individuals. With normal functioning kidneys, the retention of gadolinium in soft tissues of the body is very small and may not even be detectable. However, some patients who receive multiple doses of contrast, including pregnant women and children, might be at increased risk of gadolinium remaining in the body for longer periods of time. To date, there are no known harmful effects of gadolinium remaining in the body for long periods of time in patients who have normal kidneys. In patients who have poorly functioning kidneys, a condition called nephrogenic systemic sclerosis (NSF) can occur. This causes debilitating thickening of the skin and other tissues. This only occurs in patients with poorly functioning kidneys. Your kidney function will be checked prior to receiving gadolinium contrast agent if needed. Other side-effects can occur even in patients with healthy kidneys. Some patients report pain, tiredness, and muscle aches after receiving gadolinium contrast but these conditions have not been directly linked to the administration of the gadolinium. Allergic reactions can also occur, as with any drug. If you have questions regarding your MRI examination today, please ask your MRI Technologist. MEDICATION GUIDE MULTIHANCE® (məl-tē-han(t)s) (gadobenate dimeglumine) Injection for intravenous use What is MULTIHANCE? • MULTIHANCE is a prescription medicine called a gadolinium-based contrast agent (GBCA).
    [Show full text]
  • Gadolinium Speciation
    Gadolinium Speciation Peter Caravan Martinos Center for Biomedical Imaging Institute for Innovation in Imaging Massachusetts General Hospital and Harvard Medical School Conflicts of Interest Stock ownership (>5%): Reveal Pharmaceuticals; Collagen Medical; Factor 1A LLC. Research grants: Pfizer; Pliant Pharmaceuticals; Biogen; Agilent; Pharmakea; Siemens. Consulting: Guerbet; Bayer; Collagen Medical; UCB Biopharma; Pfizer. What do we mean by speciation? What is the chemical form of the gadolinium in tissue? Chelated Gd Dissociated Gd The GBCA remains intact Dissociation of the GBCA Gd3+ ion Is Gd bound to a low molecular weight ligand? Is Gd part of some inorganic material like hydroxyapatite? Is Gd bound to a macromolecule? If so, which one? Where is the Gd distributed within tissue? Extra vs intracellular? In which cellular compartments? Why do we care about speciation? • The chemical form of Gd may inform its potential toxicity • Mineralized, insoluble Gd may be less toxic than soluble protein bound Gd (hypothesis) • The chemical form may also inform whether the Gd will be ultimately eliminated. Intact chelate may be expected to eventually clear the body (hypothesis). • The chemical form and location may guide chelation therapy strategies. Hierarchy of relevance of the data Human in vivo Human ex vivo Animal in vivo Animal ex vivo Solutions To model ex vivo Water solutions Tweedle MF. Gadolinium deposition: Is it chelated or dissociated gadolinium? How can we tell? Magn Reson Imaging. 2016;34(10):1377–82. How do GBCAs differ • Thermodynamics:
    [Show full text]
  • Verse in Fraser's Magazine
    Curran Index - Table of Contents Listing Fraser's Magazine For a general introduction to Fraser's Magazine see the Wellesley Index, Volume II, pages 303-521. Poetry was not included in the original Wellesley Index, an absence lamented by Linda Hughes in her influential article, "What the Wellesley Index Left Out: Why Poetry Matters to Periodical Studies," Victorian Periodicals Review, 40 (2007), 91-125. As Professor Hughes notes, Eileen Curran was the first to attempt to remedy this situation in “Verse in Bentley’s Miscellany vols. 1-36,” VPR 32 (1999), 103-159. As one part of a wider effort on the part of several scholars to fill these gaps in Victorian periodical bibliography and attribution, the Curran Index includes a listing of verse published in Fraser's Magazine from 1831 to 1854. EDITORS: Correct typo, 2:315, 1st line under this heading: Maginn, if he was editor, held the office from February 1830, the first issue, not from 1800. [12/07] Volume 1, Feb 1830 FM 3a, A Scene from the Deluge (from the German of Gesner), 24-27, John Abraham Heraud. Signed. Verse. (03/15) FM 4a, The Standard-Bearer -- A Ballad from the Spanish, 38-39, John Gibson Lockhart. possib. Attributed by Mackenzie in introduction to Fraserian Papers Vol I; see Thrall, Rebellious Fraser: 287 Verse. (03/15) FM 4b, From the Arabic, 39, Unknown. Verse. (03/15) FM 5a, Posthumous Renown, 44-45, Unknown. Verse. (03/15) FM 6a, The Fallen Chief (Translated from the Arabic), 54-56, Unknown. Verse. (03/15) Volume 1, Mar 1830 FM 16b, A Hard Hit for a Damosell, 144, Unknown.
    [Show full text]
  • ACR Manual on Contrast Media
    ACR Manual On Contrast Media 2021 ACR Committee on Drugs and Contrast Media Preface 2 ACR Manual on Contrast Media 2021 ACR Committee on Drugs and Contrast Media © Copyright 2021 American College of Radiology ISBN: 978-1-55903-012-0 TABLE OF CONTENTS Topic Page 1. Preface 1 2. Version History 2 3. Introduction 4 4. Patient Selection and Preparation Strategies Before Contrast 5 Medium Administration 5. Fasting Prior to Intravascular Contrast Media Administration 14 6. Safe Injection of Contrast Media 15 7. Extravasation of Contrast Media 18 8. Allergic-Like And Physiologic Reactions to Intravascular 22 Iodinated Contrast Media 9. Contrast Media Warming 29 10. Contrast-Associated Acute Kidney Injury and Contrast 33 Induced Acute Kidney Injury in Adults 11. Metformin 45 12. Contrast Media in Children 48 13. Gastrointestinal (GI) Contrast Media in Adults: Indications and 57 Guidelines 14. ACR–ASNR Position Statement On the Use of Gadolinium 78 Contrast Agents 15. Adverse Reactions To Gadolinium-Based Contrast Media 79 16. Nephrogenic Systemic Fibrosis (NSF) 83 17. Ultrasound Contrast Media 92 18. Treatment of Contrast Reactions 95 19. Administration of Contrast Media to Pregnant or Potentially 97 Pregnant Patients 20. Administration of Contrast Media to Women Who are Breast- 101 Feeding Table 1 – Categories Of Acute Reactions 103 Table 2 – Treatment Of Acute Reactions To Contrast Media In 105 Children Table 3 – Management Of Acute Reactions To Contrast Media In 114 Adults Table 4 – Equipment For Contrast Reaction Kits In Radiology 122 Appendix A – Contrast Media Specifications 124 PREFACE This edition of the ACR Manual on Contrast Media replaces all earlier editions.
    [Show full text]
  • Cerium Oxide Nanoparticles and Gadolinium Integration
    Linköping Studies in Science and Technology Dissertation No. 1997 Peter Eriksson Peter FACULTY OF SCIENCE AND ENGINEERING Linköping Studies in Science and Technology, Dissertation No. 1997, 2019 Cerium Oxide Nanoparticles Department of Physics, Chemistry and Biology (IFM) Linköping University SE-581 83 Linköping, Sweden and Gadolinium Integration Cerium Oxide Integration Nanoparticles and Gadolinium Synthesis, Characterization and Biomedical Applications www.liu.se Peter Eriksson 2019 Linköping Studies in Science and Technology Dissertation No. 1997 Cerium Oxide Nanoparticles and Gadolinium Integration Synthesis, Characterization and Biomedical Applications Peter Eriksson Applied Physics Department of Physics, Chemistry & Biology Linköping University, Sweden Linköping 2019 Front cover: A cerium oxide nanoparticle with integrated gadolinium. Back cover: Cross-section of a gadolinium-cerium oxide nanoparticle and its displayed theragnostic properties: left) cerium undergo redox-reactions to scavenge reactive oxygen species and right) gadolinium shorten the T1-relaxation time of nuclei spins in water molecules. During the course of the research underlying this thesis, Peter Eriksson was enrolled in Forum Scientium, a multidisciplinary doctoral programme at Linköping University, Sweden. © Copyright 2019 Peter Eriksson, unless otherwise noted Peter Eriksson Cerium Oxide Nanoparticles and Gadolinium Integration; Synthesis, Characterization and Biomedical Applications ISBN: 978-91-7685-029-9 ISSN: 0345-7524 Linköping Studies in Science and Technology,
    [Show full text]
  • Evaluating the Potential of Chelation Therapy to Prevent and Treat
    www.nature.com/scientificreports OPEN Evaluating the potential of chelation therapy to prevent and treat gadolinium deposition from Received: 29 December 2017 Accepted: 23 February 2018 MRI contrast agents Published: xx xx xxxx Julian A. Rees1, Gauthier J.-P. Deblonde1, Dahlia D. An 1, Camille Ansoborlo1, Stacey S. Gauny1 & Rebecca J. Abergel1,2 Several MRI contrast agent clinical formulations are now known to leave deposits of the heavy metal gadolinium in the brain, bones, and other organs of patients. This persistent biological accumulation of gadolinium has been recently recognized as a deleterious outcome in patients administered Gd- based contrast agents (GBCAs) for MRI, prompting the European Medicines Agency to recommend discontinuing the use of over half of the GBCAs currently approved for clinical applications. To address this problem, we fnd that the orally-available metal decorporation agent 3,4,3-LI(1,2- HOPO) demonstrates superior efcacy at chelating and removing Gd from the body compared to diethylenetriaminepentaacetic acid, a ligand commonly used in the United States in the GBCA Gadopentetate (Magnevist). Using the radiotracer 153Gd to obtain precise biodistribution data, the results herein, supported by speciation simulations, suggest that the prophylactic or post-hoc therapeutic use of 3,4,3-LI(1,2-HOPO) may provide a means to mitigate Gd retention in patients requiring contrast-enhanced MRI. Te use of gadolinium-based contrast agents (GBCAs) for magnetic resonance imaging (MRI) has been ubiqui- tous in radiology for nearly three decades1. Recently however, it has come to light that the suboptimal biological stability of GBCAs can lead to accumulation of Gd in patients’ bone and brain tissue, as well as to kidney damage and associated systemic conditions due to compromised renal function2–4.
    [Show full text]
  • Europium-DTPA: a Gadolinium Analogue Traceable by Fluorescence Microscopy
    1137 Dyke Award Europium-DTPA: A Gadolinium Analogue Traceable by Fluorescence Microscopy Allen D. Elster1 A lanthanide series chelate, europium(Eu)-DTPA, was synthesized to serve as a Susan C. Jackels2 histochemical analogue for the widely used MR contrast agent gadolinium(Gd)-DTPA. Nina S. Allen3 Eu and Gd, being neighboring elements on the periodic table, share many fundamental Ron C. Marrache2 properties, including ionic radius, valence, and chemical reactivity. Eu-DTPA, however, possesses one important physical property not shared by Gd-DTPA: luminescence under ultraviolet light. The feasibility of detecting Eu-DTPA in animal tissues under fluorescence microscopy was systematically evaluated and documented. Distinctive orange-red luminescence of Eu-DTPA could be observed in the kidneys, livers, dura, choroid, and pituitary glands of rats after intravascular injection. No lumi­ nescence was detected in areas of brain beyond an intact blood-brain barrier. When the brain was locally injured by an experimental laceration, however, leakage of Eu-DTPA was detected. Electron probe microanalysis confirmed the parallel presence or absence of simultaneously injected Eu-DTPA and Gd-DTPA in all tissues studied. Fluorescence microscopy with Eu-DTPA has thus been validated as a method for tracing the distri­ bution of Gd-DTPA at the microscopic level. AJNR 10:1137-1144, November/December 1989 The recent development of paramagnetic MR contrast agents such as gadolinium (Gd)-DTPA has been received by the radiologic community with justifiable enthu­ siasm. Like their iodinated counterparts in CT, MR contrast agents appear to offer increased sensitivity and specificity for detecting and characterizing a number of diseases affecting the nervous system [1-11 ].
    [Show full text]
  • Mythology in Poetry
    Mythology in AP Poetry Andromeda sorrowing father was close at hand, and her mother too. They were Andromeda was the princess of Ethiopia, daughter of Cepheus and both in deep distress, though the mother had more cause to be so Cassiopeia. Cassiopeia was a boastful woman, and foolishly bragged (Metamorphoses IV 674-692) Perseus said to her parents that he that she was more beautiful than Juno, the queen of the gods, and the would kill the monster if they agree to give him their daughter's hand Nereids. In order to avenge the insult to his nymphs, Neptune sent a in marriage. They of course gave their consent, and Perseus killed the sea monster to ravage the Ethiopian coast. (Some accounts state that monster. (His exact method of doing so varies in different versions of the constellation Cetus represents the sea monster, but a more the myth. Ovid has Perseus stab the monster to death after a drawn- common view of Cetus is that he is a peaceful whale.) out, bloody battle, while other versions have the hero simply hold up the head of Medusa, turning the monster to stone.) Andromeda was The horrified king consulted Ammon, the oracle of Jupiter, who said freed, and the two joyously marry. that Neptune could be appeased only by sacrificing Cassiopeia's *Andromeda is represented in the sky as the figure of a woman with beautiful virgin daughter, Andromeda, to the monster. Andromeda her arms outstretched and chained at the wrists. was duly chained to a rock on the coast, fully exposed to the monster.
    [Show full text]
  • Urania, Ceremonial Magic of the Goddess By: Olivia Robertson
    Fellowship of Isis - Online Liturgy http://www.fellowshipofisis.com Urania, Ceremonial Magic of the Goddess By: Olivia Robertson 5. Earth Magic of Transmutation ORACLE OF THE GODDESS HERTHA PRIESTESS: Divine Mother Goddess Hertha, we sing thy praise, we glorify Thy creation. "From a cracked egg's lower fragment Now the solid earth She fashioned. From the cracked egg's upper fragment, Rose the lofty arch of Heaven. From the yolk, the upper portion Now became the sun's bright lustre; From the white, the upper portion. Rose the Moon that shines so brightly; Whatso in the egg was mottled, Now became the Stars in Heaven. When the ninth year had passed over, And the summer tenth was passing, From the sea Her Head She lifted, And Her Forehead She uplifted, And She then began Creation, And She brought the world to order, On the open ocean's surface, On the far extending waters. Whereso'ere Her Hand She pointed, There She formed the jutting headlands; When towards the land She turned Her, There the level shores extended." ORACLE: Whenever the longing heart turns to the Mother, there I take up My abode. I am the Hearth Fire, the Heart of Life, and the secure earth that is your home. And this my hearth is one and yet manifold throughout the galaxies. Honour your home, the earth, not for its greatness, but for its littleness. For in this matrix is your protection. Be as my children the animals, the birds and the plants. For they die not but live forever in My everlasting home.
    [Show full text]
  • Table 2: Classical Albedo Names from Greek
    Gangale & Dudley-Flores Proposed Additions to the Cartographic Database of Mars 48 Table 2: Classical Albedo Names From Greek Feature Name Type Latitude East Longitude Origin Usage Boreosyrtis Canalis 54.68 70 Northern sandbank in Greek. 1888 Schiaparelli, 1895 Lowell, 1901 Antoniadi, 1955 BAA, 1967 IAU. Deuteronilus Canalis 34.68 0 "Second Nile" in Greek. 1888 Schiaparelli, 1895 Lowell, 1901 Antoniadi, 1905 Lowell, 1954 De Vaucouleurs, 1955 BAA, 1957 IAU. Deuteronilus Mensae 45.11 23.92 Second Nile in Greek. Mensae Deuteronilus Colles 41.95 21.7 Second Nile in Greek. Colles Hellas Regio -39.67 70 The indigenous name of Greece. 1888 Schiaparelli, 1895 Lowell, 1901 Antoniadi, 1954 De Vaucouleurs, 1955 BAA, 1957 IAU. Hellas Planitia Planitia -42.43 70.5 The indigenous name of Greece. Hellas Montes Montes -37.63 97.61 The indigenous name of Greece. Nilokeras Canalis 29.71 305 "Horn of the Nile" in Greek. 1888 Schiaparelli, 1895 Lowell, 1901 Antoniadi, 1905 Lowell, 1954 De Vaucouleurs, 1955 BAA, 1957 IAU. Nilokeras Scopulus 31.72 304.15 Horn of the Nile in Greek. Scopulus Nilokeras Fossa Fossa 24.59 302.17 Horn of the Nile in Greek. Nilokeras Mensae 30.48 308.05 Horn of the Nile in Greek. Mensae Nilosyrtis Canalis 41.66 70 "Sandbank of the Nile" in Greek. 1888 Schiaparelli, 1895 Lowell, 1901 Antoniadi, 1905 Lowell, 1954 De Vaucouleurs, 1955 BAA, 1957 IAU. Nilosyrtis Mensae 34.77 68.47 "Sandbank of the Nile" in Greek. Mensae Protonilus Mensae 43.87 48.86 "First (Eastern) part of Nile" in Greek. Mensae Gangale & Dudley-Flores Proposed Additions to the Cartographic Database of Mars 49 Feature Name Type Latitude East Longitude Origin Usage Uranius Patera Patera 26.32 267.2 "Heavenly" in Greek.
    [Show full text]
  • Enriched Gadolinium As Burnable Absorber For
    PHYSOR 2004 – The Physics of Fuel Cycles and Advanced Nuclear Systems: Global Developments Chicago, Illinois, April 25-29, 2004, on CD-ROM, American Nuclear Society, Lagrange Park, IL. (2004) Enriched Gadolinium as Burnable Absorber for PWR Klaes-Håkan Bejmer*1 and Ola Seveborn2 1Vattenfall Bränsle AB, S-162 87 Stockholm, Sweden 2Sernanders väg 5-518, S-752 61 Uppsala, Sweden Abstract This paper is a summary of a master of thesis work in reactor physics made by Ola Seveborn. The work was done at Vattenfall Bränsle AB and Ola was guided through the work by the corresponding author of this paper. The results presented are calculations for Ringhals 3, which is a Westinhouse 3- loop PWR within the Vattenfall Group. The fuel is characterized by 17x17 assemblies of AFA type containing 3.80-3.95 w/o 235U and 8 rods containing 2 w/o Gadolinium with an enrichment of 70 w/o 157Gd. The calculations were performed with the Studsvik-Scandpower code package based on the CASMO-4 lattice code and the SIMULATE-3 nodal code. The results are compared to the corresponding calculations for fuel with 5 w/o gadolinium with natural isotopic constitution. The depletion of the cores was done separately for the reference and enriched case. The results show that the gains in average for the five cycles studied are about 70 EFPH per cycle. This is an effect of the lower gadolinium content needed. Also less parasitic absorption of enriched gadolinium in the end of the fuel life contributes to the increased cycle lengths. The abruptly increased reactivity and internal power peaking factor around 10 MWd/kgU do not affect the core design negatively.
    [Show full text]
  • GADOLINIUM Element Symbol: Gd Atomic Number: 64
    GADOLINIUM Element Symbol: Gd Atomic Number: 64 An initiative of IYC 2011 brought to you by the RACI KAYE GREEN www.raci.org.au GADOLINIUM Element symbol: Gd Atomic number: 64 Spectroscopic lines due to gadolinium were first observed in 1880 by Swiss chemist Jean Charles Galissard de Marignac in samples of several rare earth oxide minerals. Then in 1886, French chemist Paul Émile Lecoq de Boisbaudran separated gadolinia, a rare earth oxide, from yttria. Elemental gadolinium was isolated only recently, and like the mineral gadolinite, is named after Finnish chemist and geologist Johan Gadolin. Elemental gadolinium is a reactive silvery-white metal, which exists in nature in the oxide minerals monazite and bastnäsite, together with other rare earth metals. Ironically, only trace amounts of gadolinium are present in the mineral gadolinite. Historically, Australia has exported significant quantities of monazite from heavy mineral sands mined in Western Australia, New South Wales and Queensland for the extraction of rare earth metals including gadolinium. However, China is both the largest supplier and user of these metals. Gadolinium has the highest thermal neutron capture cross-section of any known element and in its common trivalent oxidation state it has a single electron in each of its seven 4f valence orbitals, which gives it the equal largest number of unpaired electrons of any element. These chemical properties give rise to important medical and industrial applications for gadolinium compounds, including use as intravenous contrast agents to enhance images in medical magnetic resonance imaging and use in targeting tumours in neutron capture therapy. Gadolinium compounds are also employed for neutron shielding in nuclear reactors and for making green phosphors for colour TV tubes and compact discs.
    [Show full text]